CompletedInterventionalPhase 3Updated Nov 11, 2010
Study in Patients With Asthma | NCT00215397 | Trialant
CompletedInterventionalPhase 2Updated Nov 11, 2010
Study in Patients With Asthma
ClinicalTrials.gov ID
NCT00215397
Lead Sponsor
DeyINDUSTRY
Overall Status
Completed
Study Type
Interventional
Phase
Phase 2
Enrollment
16
Last Update Posted
Nov 11, 2010Estimated
Primary Completion Date
Feb 2003Actual
Completion Date
Dec 2005Actual
Brief Summary
The purpose of this study is to determine which dose of the investigational drug is the most safe and effective in the treatment of asthma compared to the control drug.
Asthma
Formoterol Fumarate
Ages Eligible for Study
Child (0-17)Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients with a history of asthma
Exclusion Criteria:
Current asthma exacerbation or recent asthma exacerbation, requiring hospitalization